PerimeterX, the leading provider of application security solutions that keep web businesses safe in the complex digital world, today announced that it has been named the winner of the “Overall CyberSecurity Startup of the Year” award in the 2019 CyberSecurity Breakthrough Awards program from CyberSecurity Breakthrough, a leading independent market intelligence organization that recognizes the top companies, technologies and products in the global information security market today.
Vertex Growth Fund achieves a resounding final close of its inaugural fund – Vertex Growth Fund I – at USD290 million. Demand for the fund surpassed the initial target fund size of USD250 million.
Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diabetic eye disease, today reports positive topline data from a Phase 1 study with THR-149, a novel, potent, plasma kallikrein (PKal) inhibitor for the treatment of Diabetic Macular Edema (DME).
Nuvaira deploys a ground-breaking therapy called targeted lung denervation. It’s based on the discovery that a faulty nerve that runs from the brain to the lungs may be partly to blame for asthma flare-ups.
Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, has received acceptance from the Haute Autorité de Santé (HAS, the French health technology assessment agency) into its Forfait Innovation program. The program is designed to fast-track novel medical devices with significant potential to improve clinical outcomes, with the objective of expediting access to important new therapies.
Instarem is a Singapore-based provider of innovative cross-border payment solution for retail and enterprise clients. Cross-border money transfers and transactions have been a costly and cumbersome process, with senders unable to ascertain the total cost and time needed to complete the process.